Introduction by Dr. J Duchin. Long term persistence study and vaccine supply by Dr. J Parrino and Dr. E Bresnitz. Burden of HZ disease and effectiveness of HZV in older adults by Dr. C Hales. Decision and cost-effectiveness of HZV in adults ≥50 years of age by Dr. I Ortega-Sanchez. WG considerations for use of HZV in adults 50-59 years of age by Dr. C Hales.